{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T05:10:06Z","timestamp":1769922606022,"version":"3.49.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T00:00:00Z","timestamp":1714176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T00:00:00Z","timestamp":1714176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s13555-024-01161-9","type":"journal-article","created":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T05:01:17Z","timestamp":1714194077000},"page":"1071-1077","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["When Patient Diversity Informs Formulation: Reimagining Treatment for Seborrheic Dermatitis"],"prefix":"10.1007","volume":"14","author":[{"given":"Meredith Tyree","family":"Polaskey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Woolery-Llloyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Osborne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Burnett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6510-399X","authenticated-orcid":false,"given":"Raj","family":"Chovatiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,27]]},"reference":[{"issue":"2","key":"1161_CR1","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jaad.2010.05.037","volume":"64","author":"D Rucker Wright","year":"2011","unstructured":"Rucker Wright D, Gathers R, Kapke A, Johnson D, Joseph CLM. Hair care practices and their association with scalp and hair disorders in African American girls. J Am Acad Dermatol. 2011;64(2):253\u201362. https:\/\/doi.org\/10.1016\/j.jaad.2010.05.037.","journal-title":"J Am Acad Dermatol"},{"key":"1161_CR2","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.2147\/CCID.S284671","volume":"15","author":"F Dall\u2019oglio","year":"2022","unstructured":"Dall\u2019oglio F, Nasca MR, Gerbino C, Micali G. An overview of the diagnosis and management of seborrheic dermatitis. Clin Cosmet Investig Dermatol. 2022;15:1537\u201348. https:\/\/doi.org\/10.2147\/CCID.S284671.","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"3","key":"1161_CR3","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/pde.14958","volume":"39","author":"LC Hollins","year":"2022","unstructured":"Hollins LC, Butt M, Hong J, Taylor SC. Research in brief: survey of hair care practices in various ethnic and racial pediatric populations. Pediatr Dermatol. 2022;39(3):494\u20136. https:\/\/doi.org\/10.1111\/pde.14958.","journal-title":"Pediatr Dermatol"},{"key":"1161_CR4","unstructured":"Howell MC Jr. 17 Dangerous ingredients to avoid in hair care products. https:\/\/www.consumernotice.org\/products\/dangerous-hair-care-ingredients\/. Accessed Nov 10, 2023."},{"issue":"1","key":"1161_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/cod.12580","volume":"75","author":"S Mertens","year":"2016","unstructured":"Mertens S, Gilissen L, Goossens A. Allergic contact dermatitis caused by cocamide diethanolamine. Contact Dermatitis. 2016;75(1):20\u20134. https:\/\/doi.org\/10.1111\/cod.12580.","journal-title":"Contact Dermatitis"},{"key":"1161_CR6","unstructured":"International Agency for Research on Cancer. Coconut oil diethanolamine condensate. IARC Monogr Eval Carcinog Risks to Humans. 2013;101:141\u2013148. https:\/\/monographs.iarc.fr\/wp-content\/uploads\/2018\/06\/mono101-005.pdf."},{"key":"1161_CR7","doi-asserted-by":"publisher","DOI":"10.1177\/1091581818794417","author":"I Boyer","year":"2018","unstructured":"Boyer I, Burnett CL, Bergfeld WF, et al. Safety assessment of PEGs cocamine and related ingredients as used in cosmetics. Int J Toxicol. 2018. https:\/\/doi.org\/10.1177\/1091581818794417.","journal-title":"Int J Toxicol"},{"issue":"1","key":"1161_CR8","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/DER.0000000000000307","volume":"29","author":"MA McGowan","year":"2018","unstructured":"McGowan MA, Scheman A, Jacob SE. Propylene glycol in contact dermatitis a systematic review. Dermatitis. 2018;29(1):6\u201312.","journal-title":"Dermatitis"},{"issue":"6","key":"1161_CR9","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1001\/jamadermatol.2023.0846","volume":"159","author":"MJ Zirwas","year":"2023","unstructured":"Zirwas MJ, Draelos ZD, Dubois J, et al. Efficacy of roflumilast foam, 0.3%, in patients with seborrheic dermatitis: a double-blind, vehicle-controlled phase\u00a02a randomized clinical trial. JAMA Dermatol. 2023;159(6):613\u201320. https:\/\/doi.org\/10.1001\/jamadermatol.2023.0846.","journal-title":"JAMA Dermatol"},{"key":"1161_CR10","unstructured":"Special Chem. Crodafos\u2122 CES Technical Datasheet. Universal Selector. https:\/\/cosmetics.specialchem.com\/product\/i-croda-crodafos-ces. Accessed Dec 15, 2023."},{"key":"1161_CR11","unstructured":"Osborne DW, Berk D. Treatment of skin conditions using high Krafft temperature anionic surfactants. Published online 2021:1\u201331. https:\/\/patents.google.com\/patent\/AU2021268977A1\/en. Accessed 27 Feb 2024."},{"key":"1161_CR12","unstructured":"UL Solutions. TRANSCUTOL\u00ae CG. Prospector. https:\/\/www.ulprospector.com\/en\/na\/PersonalCare\/Detail\/832\/33781\/TRANSCUTOL-CG. Accessed Dec 15, 2023."}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-024-01161-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-024-01161-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-024-01161-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T13:27:14Z","timestamp":1716470834000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-024-01161-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,27]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["1161"],"URL":"https:\/\/doi.org\/10.1007\/s13555-024-01161-9","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,27]]},"assertion":[{"value":"27 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Meredith Tyree Polaskey has no conflicts to disclose. Heather Woolery-Lloyd has served as a consultant, speaker, and\/or investigator for Ortho Dermatologics, L\u2019Or\u00e9al, Eli Lillly and Company, Incyte, Pfizer Inc., Galderma, Allergan, Arcutis, Vyne, Eirion, and Regeneron Diane Hanna and Patrick Burnett are employees of Arcutis Biotherapeutics, Inc. Diane Hanna, Patrick Burnett, and David Osborne are shareholders of Arcutis Biotherapeutics, Inc and own stock. Raj Chovatiya has served as an advisor, consultant, speaker, and\/or investigator for AbbVie, Amgen, Apogee Therapeutics, Arcutis, Argenx, ASLAN Pharmaceuticals, Beiersdorf, Boehringer Ingelheim, Bristol Myers Squibb, Cara Therapeutics, Dermavant, Eli Lilly and Company, FIDE, Galderma, Genentech, GSK, Incyte, LEO Pharma, L\u2019Or\u00e9al, Nektar Therapeutics, Novartis, Opsidio, Pfizer Inc., Regeneron, RAPT, Sanofi, Sitryx, and UCB.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}